|
Market Closed -
Other stock markets
|
Pre-market 12:05:34 | |||
| 79.90 USD | +0.31% |
|
80.18 | +0.34% |
| 07-16 | Consumer Staple Companies Likely Saw Another 'Tricky' Quarter, UBS Says | MT |
| 07-16 | UBS Adjusts Price Target on e.l.f. Beauty to $80 From $60, Maintains Neutral Rating | MT |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.8 | 7.81 | 11.09 | 8.33 | 4.77 | |||||
Return on Total Capital | 4.39 | 9.23 | 13.42 | 9.87 | 5.57 | |||||
Return On Equity % | 7.48 | 17.01 | 24.23 | 15.97 | 2.78 | |||||
Return on Common Equity | 7.48 | 17.01 | 24.23 | 15.97 | 2.78 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 64.19 | 67.44 | 70.72 | 71.24 | 70.72 | |||||
SG&A Margin | 56.48 | 55.6 | 55.75 | 59.17 | 62.23 | |||||
EBITDA Margin % | 13.01 | 14.7 | 17.34 | 13.72 | 11.2 | |||||
EBITA Margin % | 9.67 | 13.17 | 16.41 | 13.39 | 10.66 | |||||
EBIT Margin % | 7.6 | 11.77 | 14.95 | 12.06 | 8.49 | |||||
Income From Continuing Operations Margin % | 5.55 | 10.63 | 12.47 | 8.53 | 1.61 | |||||
Net Income Margin % | 5.55 | 10.63 | 12.47 | 8.53 | 1.61 | |||||
Net Avail. For Common Margin % | 5.55 | 10.63 | 12.47 | 8.53 | 1.61 | |||||
Normalized Net Income Margin | 4.13 | 6.94 | 8.99 | 6.94 | 4.07 | |||||
Levered Free Cash Flow Margin | 6.17 | 17.31 | 6.26 | 10.73 | 13.88 | |||||
Unlevered Free Cash Flow Margin | 6.46 | 17.68 | 6.94 | 11.51 | 15.4 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.8 | 1.06 | 1.19 | 1.1 | 0.9 | |||||
Fixed Assets Turnover | 11.7 | 22.41 | 32.21 | 21.13 | 17.58 | |||||
Receivables Turnover (Average Receivables) | 9.15 | 10.2 | 10.68 | 10.52 | 10.89 | |||||
Inventory Turnover (Average Inventory) | 1.99 | 2.27 | 2.2 | 2 | 2.35 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.97 | 2.81 | 1.59 | 3.05 | 2.35 | |||||
Quick Ratio | 1.37 | 1.75 | 0.78 | 1.55 | 1.38 | |||||
Operating Cash Flow to Current Liabilities | 0.3 | 0.94 | 0.24 | 0.76 | 0.63 | |||||
Days Sales Outstanding (Average Receivables) | 39.91 | 35.78 | 34.27 | 34.71 | 33.53 | |||||
Days Outstanding Inventory (Average Inventory) | 183.65 | 160.59 | 166.51 | 182.9 | 155.19 | |||||
Average Days Payable Outstanding | 37.92 | 49.9 | 50.21 | 74.88 | 60.45 | |||||
Cash Conversion Cycle (Average Days) | 185.64 | 146.47 | 150.56 | 142.73 | 128.27 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 37.45 | 19.99 | 45.22 | 41.14 | 81.1 | |||||
Total Debt / Total Capital | 27.25 | 16.66 | 31.14 | 29.15 | 44.78 | |||||
LT Debt/Equity | 34.19 | 17.54 | 28.52 | 40.14 | 77.78 | |||||
Long-Term Debt / Total Capital | 24.88 | 14.62 | 19.64 | 28.44 | 42.95 | |||||
Total Liabilities / Total Assets | 36.84 | 30.99 | 43.1 | 39.04 | 52.78 | |||||
EBIT / Interest Expense | 12.2 | 17.08 | 12.93 | 9.22 | 3.29 | |||||
EBITDA / Interest Expense | 22.79 | 22.49 | 15.62 | 11.23 | 4.72 | |||||
(EBITDA - Capex) / Interest Expense | 20.81 | 22.06 | 14.89 | 10.15 | 4.19 | |||||
Total Debt / EBITDA | 2.1 | 0.92 | 1.57 | 1.62 | 4.6 | |||||
Net Debt / EBITDA | 1.32 | -0.43 | 0.99 | 0.85 | 3.15 | |||||
Total Debt / (EBITDA - Capex) | 2.3 | 0.93 | 1.65 | 1.79 | 5.18 | |||||
Net Debt / (EBITDA - Capex) | 1.45 | -0.44 | 1.03 | 0.94 | 3.54 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.28 | 47.61 | 76.89 | 28.28 | 24.59 | |||||
Gross Profit, 1 Yr. Growth % | 22.08 | 55.08 | 85.48 | 29.22 | 23.69 | |||||
EBITDA, 1 Yr. Growth % | 59.28 | 66.87 | 108.67 | 4.89 | 1.72 | |||||
EBITA, 1 Yr. Growth % | 88.27 | 101.06 | 120.45 | 4.61 | -0.77 | |||||
EBIT, 1 Yr. Growth % | 147.65 | 128.51 | 124.64 | 3.49 | -12.27 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 249.33 | 182.64 | 107.48 | -12.2 | -76.52 | |||||
Net Income, 1 Yr. Growth % | 249.33 | 182.64 | 107.48 | -12.2 | -76.52 | |||||
Normalized Net Income, 1 Yr. Growth % | 309.75 | 147.68 | 129.21 | -0.92 | -27.02 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 241.67 | 170.73 | 99.1 | -13.12 | -77.08 | |||||
Accounts Receivable, 1 Yr. Growth % | 13.39 | 49.07 | 82.25 | 1.79 | 38.6 | |||||
Inventory, 1 Yr. Growth % | 48.74 | -3.76 | 135.47 | -2.26 | 17.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -21.57 | -24.68 | 86.52 | 100.4 | 24.42 | |||||
Total Assets, 1 Yr. Growth % | 1.49 | 20.41 | 89.6 | 10.53 | 91.81 | |||||
Tangible Book Value, 1 Yr. Growth % | -847.42 | 226.98 | -75.44 | 300.46 | -345.44 | |||||
Common Equity, 1 Yr. Growth % | 15.87 | 31.56 | 56.34 | 18.41 | 48.59 | |||||
Cash From Operations, 1 Yr. Growth % | -33.8 | 422.13 | -30.16 | 88.1 | 58.78 | |||||
Capital Expenditures, 1 Yr. Growth % | -25.58 | -64.24 | 402.55 | 113.88 | 21.21 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -31.46 | 314.13 | -35.98 | 141.38 | 61.1 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -31.57 | 304.08 | -30.51 | 131.24 | 66.75 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 17.75 | 34.89 | 61.59 | 50.64 | 26.42 | |||||
Gross Profit, 2 Yr. CAGR % | 17.89 | 37.6 | 69.6 | 54.81 | 26.43 | |||||
EBITDA, 2 Yr. CAGR % | 11.79 | 63.03 | 86.6 | 49.6 | 4.33 | |||||
EBITA, 2 Yr. CAGR % | 10.66 | 94.56 | 110.53 | 51.86 | 2.93 | |||||
EBIT, 2 Yr. CAGR % | 11.54 | 137.89 | 126.57 | 52.48 | -3.64 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 10.33 | 214.22 | 142.16 | 34.97 | -54.6 | |||||
Net Income, 2 Yr. CAGR % | 10.33 | 214.22 | 142.16 | 34.97 | -54.6 | |||||
Normalized Net Income, 2 Yr. CAGR % | 19.76 | 218.57 | 138.26 | 50.7 | -13.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.23 | 204.14 | 132.17 | 31.52 | -55.38 | |||||
Accounts Receivable, 2 Yr. CAGR % | 23.82 | 30.01 | 64.83 | 36.2 | 18.77 | |||||
Inventory, 2 Yr. CAGR % | 35.23 | 19.64 | 50.54 | 51.71 | 7.25 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -5.42 | -23.14 | 18.53 | 93.34 | 57.9 | |||||
Total Assets, 2 Yr. CAGR % | 4.48 | 10.54 | 51.1 | 44.76 | 45.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.41 | 394.36 | -10.38 | -0.82 | 213.51 | |||||
Common Equity, 2 Yr. CAGR % | 13.58 | 23.46 | 43.41 | 36.06 | 32.64 | |||||
Cash From Operations, 2 Yr. CAGR % | -33.64 | 85.92 | 90.96 | 14.62 | 72.82 | |||||
Capital Expenditures, 2 Yr. CAGR % | -28.49 | -48.41 | 34.06 | 227.85 | 61.01 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -24.21 | 68.48 | 62.81 | 21.41 | 100.89 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -25.68 | 66.29 | 67.55 | 24.34 | 99.64 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.58 | 26.96 | 47.65 | 49.62 | 41.4 | |||||
Gross Profit, 3 Yr. CAGR % | 15.58 | 29.17 | 52 | 54.9 | 43.65 | |||||
EBITDA, 3 Yr. CAGR % | 4.28 | 27.76 | 77.01 | 52.32 | 31.55 | |||||
EBITA, 3 Yr. CAGR % | 5.32 | 35.03 | 102.84 | 66.75 | 31.78 | |||||
EBIT, 3 Yr. CAGR % | 5.56 | 41.67 | 133.39 | 74.49 | 26.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 91.93 | 50.96 | 173.62 | 72.68 | -24.65 | |||||
Net Income, 3 Yr. CAGR % | 91.93 | 50.96 | 173.62 | 72.68 | -24.65 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.3 | 52.58 | 185.46 | 77.84 | 18.34 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 84.58 | 46.92 | 164.08 | 67.3 | -26.54 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.18 | 31.72 | 45.51 | 40.36 | 36.99 | |||||
Inventory, 3 Yr. CAGR % | 24.51 | 20.73 | 49.94 | 30.36 | 39.39 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.76 | -12.33 | 3.29 | 41.21 | 66.92 | |||||
Total Assets, 3 Yr. CAGR % | 4.64 | 9.54 | 32.32 | 36.14 | 59 | |||||
Tangible Book Value, 3 Yr. CAGR % | -4.54 | 51.78 | 81.74 | 47.61 | 34.15 | |||||
Common Equity, 3 Yr. CAGR % | 13.23 | 19.28 | 33.57 | 34.54 | 40.11 | |||||
Cash From Operations, 3 Yr. CAGR % | -30.75 | 31.98 | 34.15 | 90 | 27.77 | |||||
Capital Expenditures, 3 Yr. CAGR % | -20.54 | -43.24 | 10.18 | 56.65 | 135.31 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 33.49 | 22.02 | 79.93 | 33.42 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 30.68 | 24.31 | 81.38 | 37.12 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 30.78 | 35.95 | 38.76 | |||||
Gross Profit, 5 Yr. CAGR % | - | - | 34.74 | 38.88 | 41.2 | |||||
EBITDA, 5 Yr. CAGR % | - | - | 31.61 | 34.59 | 41.76 | |||||
EBITA, 5 Yr. CAGR % | - | - | 38.95 | 41.53 | 54 | |||||
EBIT, 5 Yr. CAGR % | - | - | 43.27 | 45.89 | 63.1 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 110.64 | 44.35 | 33.39 | |||||
Net Income, 5 Yr. CAGR % | - | - | 110.64 | 44.35 | 33.39 | |||||
Normalized Net Income, 5 Yr. CAGR % | - | - | 52.53 | 51.82 | 75.86 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | 102.31 | 40.56 | 29.67 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | 30.85 | 33.5 | 34.16 | |||||
Inventory, 5 Yr. CAGR % | - | - | 34.33 | 32.28 | 31.13 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 11.95 | 20.29 | 22.4 | |||||
Total Assets, 5 Yr. CAGR % | - | - | 21.21 | 22.47 | 37.48 | |||||
Tangible Book Value, 5 Yr. CAGR % | - | - | -6.92 | 28.02 | 126.03 | |||||
Common Equity, 5 Yr. CAGR % | - | - | 24.45 | 25.73 | 33.2 | |||||
Cash From Operations, 5 Yr. CAGR % | - | - | 3.9 | 24.74 | 48.45 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | - | -2.05 | 14.47 | 28.23 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 27.32 | 45.1 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 26.93 | 46.76 |
- Stock Market
- Stocks
- ELF Stock
- Financials ELF Beauty
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















